ACIU

Ac Immune Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 2/10
  • Momentum↑ 5/10
Ac Immune sales and earnings growth
ACIU Growth
Fair
  • Revenue Y/Y↓ -89.33%
  • EPS Y/Y↓ -80.00%
  • FCF Y/Y↓ -218.44%
Ac Immune gross and profit margin trends
ACIU Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -1643.90%
  • ROIC↓ -248.70%
Ac Immune net debt vs free cash flow
ACIU Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -398.3

Ac Immune stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗